Informationen:
Fehler:
ID
12978
Beschreibung
Thalidomide in Combination With Capecitabine in Patients With Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00193102
Link
https://clinicaltrials.gov/show/NCT00193102
Stichworte
Versionen (1)
- 09.01.16 09.01.16 -
Hochgeladen am
9. Januar 2016
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Breast Cancer NCT00193102
Eligibility Breast Cancer NCT00193102
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Breast Cancer NCT00193102
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
biopsy metastasis
Item
metastatic breast cancer confirmed by biopsy
boolean
C0005558 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,2])
measurable disease
Item
measurable or evaluable disease
boolean
C1513041 (UMLS CUI [1])
age, gender
Item
females > 18 years
boolean
C0001779 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
C0079399 (UMLS CUI [2])
performance status
Item
able to perform activities of daily living with minimal assistance
boolean
C1518965 (UMLS CUI [1])
life expectancy
Item
life expectancy > 3 months
boolean
C0023671 (UMLS CUI [1])
bone marrow, liver and kidney function
Item
adequate bone marrow, liver and kidney function
boolean
C0232741 (UMLS CUI [1])
C0005953 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
C0005953 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
informed consent
Item
all patients must give written informed consent in order to participate.
boolean
C0021430 (UMLS CUI [1])
pregnancy, lactation
Item
women who are pregnant or lactating.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
chemotherapy
Item
received more than 3 prior chemotherapy regimens in the metastatic setting.
boolean
C0392920 (UMLS CUI [1])
fluorouracil
Item
received continuous infusion 5-fluorouracil lasting > 120 hours.
boolean
C0016360 (UMLS CUI [1])
thalidomide, capecitabine
Item
received thalidomide or capecitabine as their last prior regimen.
boolean
C0039736 (UMLS CUI [1])
C0671970 (UMLS CUI [2])
C0671970 (UMLS CUI [2])
neuropathy
Item
preexisting moderate to severe neuropathy
boolean
C0442874 (UMLS CUI [1])
additional inclusion/exclusion criteria
Item
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
boolean